EUVIMEDEUVIMED entdecken
Validierungsstudie

Development and validation of the Red Flags Index for Crohn’s disease in high-risk populations in Korea

Ok Kim, Sihyun Kim, Hyun Jung Lee, Jong Pil Im, Byeong Gwan Kim, Joo Sung Kim, Seong Jin Jo, Hyunsun Park, Eun Kyoung Lee, Jun Won Park, Kwang Woo Kim, Ji Won Kim und 3 weitere

Digestive and Liver Disease · 2025

DOI: 10.1016/j.dld.2025.11.001 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Digestive and Liver Disease, 2025. Verfasst von Ok Kim und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, South Korea. Hauptthemen laut MEDLINE: Crohn Disease, Leukocyte L1 Antigen Complex. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: National Research Foundation, National Research Foundation of Korea, Ministry of Science and ICT, South Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND AIMS: The increasing prevalence of Crohn's disease (CD) in South Korea has led to complications and reduced quality of life, emphasizing the need for early, non-invasive diagnosis. The International Organization for Inflammatory Bowel Disease (IO-IBD) developed the Red Flag Index (RFI) for early CD detection; however, it remains to be validated in the Korean population. This study aimed to develop and validate a Korea-specific RFI for early CD diagnosis using clinical and biomarker data. METHODS: Data from 121 patients with CD at Seoul National University Hospital were compared with those from two control groups: Group A (101 non-CD individuals) and Group B (198 high-risk individuals). The participants answered 15 IO-IBD-derived questions. Chi-square tests and logistic regression were used to identify key RFI predictors. Receiver operating characteristic (ROC) analysis was used to evaluate diagnostic performance, with subgroup analyses adjusted for RFI scores. The effect of fecal calprotectin on accuracy was also assessed. RESULTS: RFI identified key CD predictors: perianal lesions, weight loss, chronic anemia, chronic/nocturnal diarrhea, perianal pain, male sex, and fecal calprotectin >100 µg/g. The RFI's area under the curve (AUC) was 0.77 (Control A) and 0.88 (Control B), improving to 0.878 and 0.92, respectively, with fecal calprotectin. Subgroup analyses confirmed RFI's enhanced diagnostic accuracy, particularly in high-risk groups, except for the ankylosing spondylitis subgroup, which had lower AUCs. CONCLUSION: RFI demonstrated strong diagnostic performance, particularly when combined with fecal calprotectin, reinforcing its applicability in stratifying high-risk populations for early and accurate CD detection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Crohn DiseaseLeukocyte L1 Antigen ComplexHumansMaleFemaleRepublic of KoreaAdultMiddle AgedBiomarkersROC CurveFecesLogistic ModelsEarly DiagnosisYoung AdultCase-Control StudiesDiarrheaSeverity of Illness IndexAnemiaSurveys and QuestionnairesRisk FactorsWeight Loss

Stichwörter der Autor:innen

Crohn’s diseaseHigh-risk groupRed Flag Index

Substanzen

Leukocyte L1 Antigen ComplexBiomarkers

Autor:innen und Institutionen

  • Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, South Korea.
  • Department of Dermatology, Seoul National University College of Medicine, Seoul, South Korea.
  • Department of Laboratory of Intestinal Mucosa and Skin Immunology, Seoul National University College of Medicine, Seoul, South Korea; Department of Dermatology, Seoul National University College of Medicine, Seoul, Sout…
  • Department of Ophthalmology, Seoul National University Hospital, Seoul, South Korea.
  • Department of Rheumatology, Seoul National University Hospital, Seoul, South Korea.
  • Department of Internal Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul National University College of Medicine, Seoul, South Korea.

Förderung

  • National Research Foundation
  • National Research Foundation of Korea
  • Ministry of Science and ICT, South Korea

Zitieren

APA

Kim, O., Kim, S., Lee, H. J., Im, J. P., Kim, B. G., Kim, J. S., Jo, S. J., Park, H., Lee, E. K., Park, J. W., Kim, K. W., Kim, J. W., Kang, H. W., Lee, J. B., & Koh, S. J. (2025). Development and validation of the Red Flags Index for Crohn’s disease in high-risk populations in Korea. Digestive and Liver Disease. https://doi.org/10.1016/j.dld.2025.11.001

Vancouver

Kim O, Kim S, Lee HJ, Im JP, Kim BG, Kim JS, et al. Development and validation of the Red Flags Index for Crohn’s disease in high-risk populations in Korea. Digestive and Liver Disease. 2025. doi:10.1016/j.dld.2025.11.001

BibTeX
@article{Kim2025,
  author = {Kim, Ok and Kim, Sihyun and Lee, Hyun Jung and Im, Jong Pil and Kim, Byeong Gwan and Kim, Joo Sung and Jo, Seong Jin and Park, Hyunsun and Lee, Eun Kyoung and Park, Jun Won and Kim, Kwang Woo and Kim, Ji Won and Kang, Hyoun Woo and Lee, Jeong Been and Koh, Seong-Joon},
  title = {Development and validation of the Red Flags Index for Crohn’s disease in high-risk populations in Korea},
  journal = {Digestive and Liver Disease},
  year = {2025},
  doi = {10.1016/j.dld.2025.11.001}
}
Kostenlos starten →